Indrayani Biotech (BSE: INDRANIB) had a P/E of 19.6× on 6 Nov 2026, above the industry P/E of 16.3×, and the shares are 51% below their 52-week high. Sales and net profit fell 5.4% and 37% a year over 3 years; its ROCE of 6.2% is the lowest among the 7 largest Specialty Business Services peers. Debt is 1.26× equity. It is a small-cap company with a market cap of ₹36 Cr, ranked 35th of 52 Specialty Business Services companies by market cap; the shares fell 43% over the past year.
- ₹7.80
- ₹8.29
- ₹7.66
- ₹8.06
- 24.3K
Health check
- ReturnsBehind
−43.5% over a year, better than 1 of 7 peers.
- Price tagPricier
P/E 19.6 vs industry 16.3.
- GrowthShrinking
Sales −5.4%, profit −37.2% a year over 3 years.
- ProfitabilityWeak
ROCE 6.2% vs peer median 16.6%.
- Balance sheetStretched
Debt 1.26× equity, interest covered 1.0×, Piotroski 7 of 9.
- Red flags3 to check
Return on equity is low at 3.0%.
Small cap
Defensive
Key metrics
- Market cap
- ₹36 Cr
- Small cap
- P/E
- 19.6
- Industry 16.3
- Price to book
- 0.49
- Peers 3.73
- Dividend yield
- 0.00%
- ROE
- 3.0%
- Peers 15.5%
- ROCE
- 6.2%
- Peers 16.6%
- Debt to equity
- 1.26
- Debt ₹128 Cr
- EPS (TTM)
- ₹0.40
- OPM (TTM)
- 6.5%
- Net margin 0.5%
- Sales growth
- +29.6%
- Latest quarter vs a year ago
- Profit growth
- +245.0%
- Latest quarter vs a year ago
- Price to sales
- 0.24
- EV/EBITDA 21.2
Strengths and risks
Strengths
- Quarterly profit up 245.0% on a year ago.
- Quarterly sales up 29.6% on a year ago.
Risks to check
- Return on equity is low at 3.0%.
- 51% below its 52-week high.
- Interest coverage of only 1.0×.
About Indrayani Biotech
Indrayani Biotech Limited, together with its subsidiaries, engages in the food and hospitality, dairy, healthcare and pharma, engineering, biotech, agriculture, and infrastructure businesses. It offers catering and food supply services. The company also designs, develops, manufactures, maintains, and services power electronics, including FCBC, battery chargers, modulars, industrial and commercial on-line UPS systems, industrial inverters, AC/DC power…
- Headquarters
- Chennai
- Sector
- Industrials
- ISIN
- INE007C01021
- Website
- indrayani.com
Price range
- Avg volume (3M)
- 60.2K
- 1-year return
- minus 43.5%
- From 52-week high
- minus 50.8%
Peers · Specialty Business Services
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLSBLS International Services | 223.35 | minus 1.55% | 9,192 | 12.9 | 3.73 | 26.1% | 32.7% | 26.4% | 25.5% | 50.7% | 1.14% | minus 29.5% |
| PDSLPDS | 403.90 | plus 0.45% | 5,704 | 48.7 | 3.23 | 16.6% | 6.6% | 2.9% | 6.9% | −25.0% | 0.92% | plus 6.5% |
| FUSIONCXFusion CX | 270.70 | minus 2.70% | 3,908 | 18.1 | 5.52 | 33.0% | 37.0% | 11.9% | 21.0% | 68.1% | 0.00% | minus 6.5% |
| CMSINFOCMS Info Systems | 215.99 | minus 0.62% | 3,457 | 12.2 | 1.46 | 16.2% | 12.9% | 25.0% | 9.1% | 0.7% | 2.31% | minus 40.0% |
| JAYKAYJaykay Enterprises | 201.05 | minus 4.29% | 3,033 | 13.9 | 4.08 | 30.6% | 40.5% | 10.7% | 72.2% | 220.1% | 0.00% | minus 5.0% |
| LORDSMARKLord's Mark Industries | 70.61 | minus 0.51% | 3,012 | 35.1 | 2.85 | 7.0% | 15.5% | 13.2% | 1716.6% | – | 0.00% | minus 88.9% |
| BLSEBLS E-Services | 149.81 | plus 1.81% | 2,719 | 62.2 | 4.90 | 16.3% | 12.6% | 6.7% | 66.3% | 44.9% | 0.33% | plus 45.5% |
| INDRANIBIndrayani Biotech | 7.85 | minus 2.61% | 36 | 19.6 | 0.49 | 6.2% | 3.0% | 6.5% | −5.4% | −37.2% | 0.00% | minus 43.5% |
| Median of 7 peers | – | −0.62% | 3,457 | 18.1 | 3.73 | 16.6% | 15.5% | 11.9% | 25.5% | 47.8% | 0.33% | −6.5% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 29.1 | 35.9 | 35 | 72.8 | 37.7 | |
| 26.9 | 33.5 | 32.2 | 67.8 | 36.2 | |
| 2.2 | 2.4 | 2.8 | 5 | 1.5 | |
| 7.5% | 6.8% | 8.0% | 6.9% | 3.9% | |
| 1.1 | 1.8 | 0.8 | 1.7 | 1.6 | |
| 2.2 | 1.9 | 2.5 | 5.5 | 1.4 | |
| 0.9 | 1.3 | 1 | 2.1 | 1.1 | |
| 0.2 | 1.1 | 0.1 | −1 | 0.6 | |
| 25.0% | 14.0% | 18.9% | 212.6% | 8.3% | |
| 0.2 | 0.9 | 0.1 | 1.1 | 0.5 | |
| 0.02 | 0.09 | 0.01 | 0.24 | 0.06 |
Profit & loss
- Sales CAGR 3Y
- −5.4%
- Profit CAGR 3Y
- −37.2%
- EPS CAGR 3Y
- −38.4%
- ROE
- 3.0%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 163 | 166 | 130 | 138 | |
| – | +2.0% | minus 21.7% | +5.8% | |
| 146 | 143 | 124 | 128 | |
| 17.3 | 23.7 | 6.3 | 9.6 | |
| 10.6% | 14.2% | 4.8% | 7.0% | |
| 3.8 | 1 | 3.1 | 4.6 | |
| 5 | 9.9 | 11.8 | 9.6 | |
| 3.3 | 3.8 | 3.4 | 4.3 | |
| −0.4 | – | – | – | |
| 12.3 | 11 | −5.7 | 0.3 | |
| 3.0% | 5.0% | −6.3% | −620.3% | |
| 8.7 | 10.4 | −6.1 | 2.2 | |
| – | +19.3% | minus 158.6% | – | |
| 2.05 | 1.40 | -1.35 | 0.48 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 43.5 | 45.5 | 45.5 | 45.5 | |
| 11.6 | 21.7 | 27 | 27.4 | |
| 70.2 | 113 | 137 | 128 | |
| 30.7 | 54.3 | 58.3 | 52.2 | |
| 156 | 234 | 268 | 253 | |
| 47.9 | 59.4 | 61 | 63.6 | |
| 13.7 | 20.3 | 25.7 | 26.7 | |
| 0 | 0 | – | 3.9 | |
| 3 | 0.6 | 0.3 | 24.6 | |
| 91.3 | 154 | 181 | 135 | |
| 156 | 234 | 268 | 253 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 16.2 | −30.4 | −6.7 | 31.7 | |
| −47.4 | −16.3 | 24.7 | −12.7 | |
| 32.7 | 44.2 | −18.3 | −15 | |
| 1.5 | −2.5 | −0.3 | 4 | |
| −43.4 | −16.5 | −1.4 | −6.9 | |
| −27.2 | −46.8 | −8.1 | 24.8 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.